Becton Dickinson and Co BDX shares are trading lower on Wednesday.
The company announced an offering of $1.5 billion of common stock and $1.5 billion of Depositary shares representing interests in mandatory convertible preferred stock.
Becton, Dickinson distributes medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems.
BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Becton Dickinson was trading down 6.33% at $246.54 on Wednesday. The stock has a 52-week high of $286.72 and a 52-week low of $197.75.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
